| Medicare NCD | NCD 110.18 - Aprepitant for Chemotherapy-Induced Emesis | 2026-09-01 |
| Medicare NCD | NCD 150.3 - Bone (Mineral) Density Studies | 2026-09-01 |
| Medicare NCD | NCD 110.24 - Chimeric Antigen Receptor (CAR) T-cell Therapy | 2026-09-01 |
| Medicare NCD | NCD 20.4 - Implantable Cardioverter Defibrillators (ICDs) | 2026-09-01 |
| Medicare NCD | NCD 90.2 - Next Generation Sequencing (NGS) | 2026-09-01 |
| Medicare NCD | NCD 220.6.1 - PET for Perfusion of the Heart | 2026-09-01 |
| BCBS Florida Coverage Guidelines | Corticosteroid Intravitreal Implant and (09-J2000-35) | 2026-09-01 |
| BCBS Florida Coverage Guidelines | Site of Care Guideline for Select Non- (09-J3000-46) | 2026-09-01 |
| UHC UMR Medical and Drug | Genetic Testing for Neurological Disorders – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Assistive Communication Device | 2026-09-01 |